{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:54:37Z","timestamp":1793231677537,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"19-20","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Cancer Institute","award":["CA217934"],"award-info":[{"award-number":["CA217934"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00018-021-03925-4","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T13:03:08Z","timestamp":1629723788000},"page":"6533-6540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNF\u03b1"],"prefix":"10.1007","volume":"78","author":[{"given":"Nicole G.","family":"Rummel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luksana","family":"Chaiswing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbarao","family":"Bondada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daret K.","family":"St. Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3254-5286","authenticated-orcid":false,"given":"D. Allan","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"issue":"3","key":"3925_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10549-016-4073-8","volume":"161","author":"TS Orchard","year":"2017","unstructured":"Orchard TS et al (2017) Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits. Breast Cancer Res Treat 161(3):391\u2013398","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"3925_CR2","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00520-014-2162-y","volume":"22","author":"P Jean-Pierre","year":"2014","unstructured":"Jean-Pierre P, Johnson-Greene D, Burish TG (2014) Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development. Support Care Cancer 22(8):2251\u20132260","journal-title":"Support Care Cancer"},{"key":"3925_CR3","doi-asserted-by":"publisher","first-page":"118071","DOI":"10.1016\/j.lfs.2020.118071","volume":"258","author":"NM Mounier","year":"2020","unstructured":"Mounier NM et al (2020) Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis. Life Sci 258:118071","journal-title":"Life Sci"},{"issue":"4","key":"3925_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11764-009-0098-x","volume":"3","author":"N Boykoff","year":"2009","unstructured":"Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors\u2019 reports of impact on work, social networks, and health care response. J Cancer Surviv 3(4):223\u2013232","journal-title":"J Cancer Surviv"},{"issue":"3","key":"3925_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10549-010-1088-4","volume":"123","author":"BC McDonald","year":"2010","unstructured":"McDonald BC et al (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 123(3):819\u2013828","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3925_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1200\/JCO.2016.68.5826","volume":"35","author":"MC Janelsins","year":"2017","unstructured":"Janelsins MC et al (2017) Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter Prospective Longitudinal Study. J Clin Oncol 35(5):506\u2013514","journal-title":"J Clin Oncol"},{"issue":"1","key":"3925_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10549-007-9686-5","volume":"110","author":"TA Ahles","year":"2008","unstructured":"Ahles TA et al (2008) Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 110(1):143\u2013152","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"3925_CR8","doi-asserted-by":"publisher","first-page":"e81234","DOI":"10.1371\/journal.pone.0081234","volume":"8","author":"YT Cheung","year":"2013","unstructured":"Cheung YT et al (2013) Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research. PLoS One 8(12):e81234","journal-title":"PLoS One"},{"issue":"1","key":"3925_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11682-017-9674-2","volume":"12","author":"RL Barry","year":"2018","unstructured":"Barry RL et al (2018) In vivo neuroimaging and behavioral correlates in a rat model of chemotherapy-induced cognitive dysfunction. Brain Imaging Behav 12(1):87\u201395","journal-title":"Brain Imaging Behav"},{"issue":"54","key":"3925_CR10","doi-asserted-by":"publisher","first-page":"30324","DOI":"10.18632\/oncotarget.25718","volume":"9","author":"JTR Keeney","year":"2018","unstructured":"Keeney JTR et al (2018) Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (\u201cchemobrain\u201d). Oncotarget 9(54):30324\u201330339","journal-title":"Oncotarget"},{"issue":"9","key":"3925_CR11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2174\/1570159X18666200221113842","volume":"18","author":"A Das","year":"2020","unstructured":"Das A et al (2020) An overview on chemotherapy-induced cognitive impairment and potential role of antidepressants. Curr Neuropharmacol 18(9):838\u2013851","journal-title":"Curr Neuropharmacol"},{"key":"3925_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbr.2015.10.057","volume":"299","author":"R Seigers","year":"2016","unstructured":"Seigers R et al (2016) Neurobiological changes by cytotoxic agents in mice. Behav Brain Res 299:19\u201326","journal-title":"Behav Brain Res"},{"issue":"3","key":"3925_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrc2073","volume":"7","author":"TA Ahles","year":"2007","unstructured":"Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7(3):192\u2013201","journal-title":"Nat Rev Cancer"},{"key":"3925_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbr.2017.05.011","volume":"330","author":"LM Pyter","year":"2017","unstructured":"Pyter LM et al (2017) Novel rodent model of breast cancer survival with persistent anxiety-like behavior and inflammation. Behav Brain Res 330:108\u2013117","journal-title":"Behav Brain Res"},{"issue":"6","key":"3925_CR15","doi-asserted-by":"publisher","first-page":"12075","DOI":"10.15252\/emmm.202012075","volume":"12","author":"LD Nguyen","year":"2020","unstructured":"Nguyen LD, Ehrlich BE (2020) Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Mol Med 12(6):12075","journal-title":"EMBO Mol Med"},{"key":"3925_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.phrs.2017.01.001","volume":"117","author":"X Ren","year":"2017","unstructured":"Ren X, St Clair DK, Butterfield DA (2017) Dysregulation of cytokine mediated chemotherapy induced cognitive impairment. Pharmacol Res 117:267\u2013273","journal-title":"Pharmacol Res"},{"issue":"3","key":"3925_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1200\/JCO.2011.36.8571","volume":"30","author":"S Deprez","year":"2012","unstructured":"Deprez S et al (2012) Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 30(3):274\u2013281","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"3925_CR18","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.bbi.2012.05.007","volume":"30","author":"BC McDonald","year":"2013","unstructured":"McDonald BC et al (2013) Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun 30(Suppl):S117\u2013S125","journal-title":"Brain Behav Immun"},{"issue":"11","key":"3925_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10(11):1387\u20131394","journal-title":"Nat Neurosci"},{"issue":"11","key":"3925_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrc2507","volume":"8","author":"B Seruga","year":"2008","unstructured":"Seruga B et al (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8(11):887\u2013899","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3925_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cyto.2014.12.006","volume":"72","author":"XM Wang","year":"2015","unstructured":"Wang XM et al (2015) Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine 72(1):86\u201396","journal-title":"Cytokine"},{"issue":"12","key":"3925_CR22","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/ijc.30252","volume":"139","author":"HR Wardill","year":"2016","unstructured":"Wardill HR et al (2016) Cytokine-mediated blood brain barrier disruption as a conduit for cancer\/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int J Cancer 139(12):2635\u20132645","journal-title":"Int J Cancer"},{"key":"3925_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2015.04.010","volume":"49","author":"A Schrepf","year":"2015","unstructured":"Schrepf A, Lutgendorf SK, Pyter LM (2015) Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents. Brain Behav Immun 49:1\u201317","journal-title":"Brain Behav Immun"},{"issue":"47","key":"3925_CR24","doi-asserted-by":"publisher","first-page":"20518","DOI":"10.1073\/pnas.1014557107","volume":"107","author":"N Terrando","year":"2010","unstructured":"Terrando N et al (2010) Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci USA 107(47):20518\u201320522","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3925_CR25","first-page":"3046","volume":"12","author":"J Zhao","year":"2020","unstructured":"Zhao J et al (2020) Changes in plasma IL-1beta, TNF-alpha and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients. Am J Transl Res 12(6):3046\u20133056","journal-title":"Am J Transl Res"},{"issue":"Suppl","key":"3925_CR26","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.bbi.2012.07.015","volume":"30","author":"PA Ganz","year":"2013","unstructured":"Ganz PA et al (2013) Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun 30(Suppl):S99-108","journal-title":"Brain Behav Immun"},{"key":"3925_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s40064-016-2030-y","volume":"5","author":"V Jenkins","year":"2016","unstructured":"Jenkins V et al (2016) A feasibility study exploring the role of pre-operative assessment when examining the mechanism of \u201cchemo-brain\u201d in breast cancer patients. Springerplus 5:390","journal-title":"Springerplus"},{"key":"3925_CR28","first-page":"12","volume":"1","author":"T Tian","year":"2014","unstructured":"Tian T, Wang M, Ma D (2014) TNF-alpha, a good or bad factor in hematological diseases? Stem Cell Investig 1:12","journal-title":"Stem Cell Investig"},{"issue":"10","key":"3925_CR29","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1097\/j.pain.0000000000001921","volume":"161","author":"G Laumet","year":"2020","unstructured":"Laumet G et al (2020) Interleukin-10 resolves pain hypersensitivity induced by cisplatin by reversing sensory neuron hyperexcitability. Pain 161(10):2344\u20132352","journal-title":"Pain"},{"issue":"11","key":"3925_CR30","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.freeradbiomed.2011.03.009","volume":"50","author":"CD Aluise","year":"2011","unstructured":"Aluise CD et al (2011) 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-alpha release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radic Biol Med 50(11):1630\u20131638","journal-title":"Free Radic Biol Med"},{"key":"3925_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2014.06.006","volume":"74","author":"DA Butterfield","year":"2014","unstructured":"Butterfield DA (2014) The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment. Free Radic Biol Med 74:157\u2013174","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"3925_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2015.07.023","volume":"367","author":"JT Keeney","year":"2015","unstructured":"Keeney JT et al (2015) Superoxide induces protein oxidation in plasma and TNF-alpha elevation in macrophage culture: Insights into mechanisms of neurotoxicity following doxorubicin chemotherapy. Cancer Lett 367(2):157\u2013161","journal-title":"Cancer Lett"},{"issue":"3","key":"3925_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jnr.21158","volume":"85","author":"G Joshi","year":"2007","unstructured":"Joshi G et al (2007) Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain. J Neurosci Res 85(3):497\u2013503","journal-title":"J Neurosci Res"},{"issue":"1","key":"3925_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2006.02.013","volume":"23","author":"J Tangpong","year":"2006","unstructured":"Tangpong J et al (2006) Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity. Neurobiol Dis 23(1):127\u2013139","journal-title":"Neurobiol Dis"},{"issue":"3","key":"3925_CR35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuroscience.2010.01.021","volume":"166","author":"G Joshi","year":"2010","unstructured":"Joshi G et al (2010) Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neuroscience 166(3):796\u2013807","journal-title":"Neuroscience"},{"key":"3925_CR36","doi-asserted-by":"publisher","first-page":"113118","DOI":"10.1016\/j.expneurol.2019.113118","volume":"324","author":"B Ongnok","year":"2020","unstructured":"Ongnok B, Chattipakorn N, Chattipakorn SC (2020) Doxorubicin and cisplatin induced cognitive impairment: the possible mechanisms and interventions. Exp Neurol 324:113118","journal-title":"Exp Neurol"},{"key":"3925_CR37","doi-asserted-by":"publisher","first-page":"104777","DOI":"10.1016\/j.neuint.2020.104777","volume":"138","author":"SA Wahdan","year":"2020","unstructured":"Wahdan SA et al (2020) Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks. Neurochem Int 138:104777","journal-title":"Neurochem Int"},{"issue":"12","key":"3925_CR38","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3390\/cancers11122002","volume":"11","author":"KL Owen","year":"2019","unstructured":"Owen KL, Brockwell NK, Parker BS (2019) JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression. Cancers (Basel) 11(12):2002","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3925_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","volume":"15","author":"F Seif","year":"2017","unstructured":"Seif F et al (2017) The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal 15(1):23","journal-title":"Cell Commun Signal"},{"issue":"6","key":"3925_CR40","doi-asserted-by":"publisher","first-page":"C1640","DOI":"10.1152\/ajpcell.1998.275.6.C1640","volume":"275","author":"AR Simon","year":"1998","unstructured":"Simon AR et al (1998) Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 275(6):C1640\u2013C1652","journal-title":"Am J Physiol"},{"key":"3925_CR41","doi-asserted-by":"publisher","first-page":"580135","DOI":"10.1155\/2013\/580135","volume":"2013","author":"C Lee","year":"2013","unstructured":"Lee C et al (2013) TNF alpha mediated IL-6 secretion is regulated by JAK\/STAT pathway but not by MEK phosphorylation and AKT phosphorylation in U266 multiple myeloma cells. Biomed Res Int 2013:580135","journal-title":"Biomed Res Int"},{"issue":"6","key":"3925_CR42","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.4049\/jimmunol.160.6.2742","volume":"160","author":"D Guo","year":"1998","unstructured":"Guo D et al (1998) Induction of Jak\/STAT signaling by activation of the type 1 TNF receptor. J Immunol 160(6):2742\u20132750","journal-title":"J Immunol"},{"issue":"1","key":"3925_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0898-6568(99)00071-6","volume":"12","author":"K Ono","year":"2000","unstructured":"Ono K, Han J (2000) The p38 signal transduction pathway: activation and function. Cell Signal 12(1):1\u201313","journal-title":"Cell Signal"},{"issue":"1","key":"3925_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.cr.7290262","volume":"15","author":"J Liu","year":"2005","unstructured":"Liu J, Lin A (2005) Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15(1):36\u201342","journal-title":"Cell Res"},{"key":"3925_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fcell.2016.00053","volume":"4","author":"R Busca","year":"2016","unstructured":"Busca R, Pouyssegur J, Lenormand P (2016) ERK1 and ERK2 Map kinases: specific roles or functional redundancy? Front Cell Dev Biol 4:53","journal-title":"Front Cell Dev Biol"},{"issue":"13","key":"3925_CR46","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1038\/sj.onc.1206290","volume":"22","author":"T Ohtsuka","year":"2003","unstructured":"Ohtsuka T et al (2003) Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK\/p38 and mitochondrial death pathway. Oncogene 22(13):2034\u20132044","journal-title":"Oncogene"},{"issue":"7","key":"3925_CR47","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.tiv.2011.05.006","volume":"25","author":"JM An","year":"2011","unstructured":"An JM et al (2011) Carmustine induces ERK- and JNK-dependent cell death of neuronally-differentiated PC12 cells via generation of reactive oxygen species. Toxicol In Vitro 25(7):1359\u20131365","journal-title":"Toxicol In Vitro"},{"issue":"40","key":"3925_CR48","doi-asserted-by":"publisher","first-page":"13289","DOI":"10.1523\/JNEUROSCI.0538-14.2014","volume":"34","author":"RY Liu","year":"2014","unstructured":"Liu RY et al (2014) Doxorubicin attenuates serotonin-induced long-term synaptic facilitation by phosphorylation of p38 mitogen-activated protein kinase. J Neurosci 34(40):13289\u201313300","journal-title":"J Neurosci"},{"issue":"10","key":"3925_CR49","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1007\/s12035-019-1589-z","volume":"56","author":"C Bagnall-Moreau","year":"2019","unstructured":"Bagnall-Moreau C et al (2019) Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Mol Neurobiol 56(10):7159\u20137172","journal-title":"Mol Neurobiol"},{"key":"3925_CR50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fncel.2019.00363","volume":"13","author":"M Miranda","year":"2019","unstructured":"Miranda M et al (2019) Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci 13:363","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"3925_CR51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1460-9568.2008.06325.x","volume":"28","author":"S Mustafa","year":"2008","unstructured":"Mustafa S et al (2008) 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci 28(2):323\u2013330","journal-title":"Eur J Neurosci"},{"issue":"6","key":"3925_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0166-2236(02)02143-4","volume":"25","author":"CW Cotman","year":"2002","unstructured":"Cotman CW, Berchtold NC (2002) Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25(6):295\u2013301","journal-title":"Trends Neurosci"},{"key":"3925_CR53","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neuropharm.2018.02.013","volume":"133","author":"HS Park","year":"2018","unstructured":"Park HS et al (2018) Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain. Neuropharmacology 133:451\u2013461","journal-title":"Neuropharmacology"},{"issue":"1","key":"3925_CR54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1471-4159.2006.04179.x","volume":"100","author":"J Tangpong","year":"2007","unstructured":"Tangpong J et al (2007) Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain. J Neurochem 100(1):191\u2013201","journal-title":"J Neurochem"},{"issue":"7","key":"3925_CR55","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1007\/s12035-017-0797-7","volume":"55","author":"SE El-Agamy","year":"2018","unstructured":"El-Agamy SE et al (2018) Astaxanthin ameliorates doxorubicin-induced cognitive impairment (chemobrain) in experimental rat model: impact on oxidative, inflammatory, and apoptotic machineries. Mol Neurobiol 55(7):5727\u20135740","journal-title":"Mol Neurobiol"},{"issue":"22","key":"3925_CR56","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1021\/acs.jafc.9b02102","volume":"67","author":"C Yang","year":"2019","unstructured":"Yang C et al (2019) Anti-inflammatory effects of different astaxanthin isomers and the roles of lipid transporters in the cellular transport of astaxanthin isomers in Caco-2 cell monolayers. J Agric Food Chem 67(22):6222\u20136231","journal-title":"J Agric Food Chem"},{"issue":"12","key":"3925_CR57","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/jnr.22422","volume":"88","author":"Q Huang","year":"2010","unstructured":"Huang Q et al (2010) Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP\/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment. J Neurosci Res 88(12):2618\u20132629","journal-title":"J Neurosci Res"},{"key":"3925_CR58","doi-asserted-by":"publisher","first-page":"689639","DOI":"10.1155\/2009\/689639","volume":"2009","author":"Y Al-Tonbary","year":"2009","unstructured":"Al-Tonbary Y et al (2009) Vitamin e and N-acetylcysteine as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia. Adv Hematol 2009:689639","journal-title":"Adv Hematol"},{"issue":"4","key":"3925_CR59","doi-asserted-by":"publisher","first-page":"e0124988","DOI":"10.1371\/journal.pone.0124988","volume":"10","author":"J Hayslip","year":"2015","unstructured":"Hayslip J et al (2015) Plasma TNF-alpha and soluble TNF receptor levels after doxorubicin with or without co-administration of Mesna-A randomized Cross-Over Clinical Study. PLoS ONE 10(4):e0124988","journal-title":"PLoS ONE"},{"issue":"1","key":"3925_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/br.2020.1377","volume":"14","author":"M Kinra","year":"2021","unstructured":"Kinra M et al (2021) Neuroprotective effect of Mulmina against chemotherapy-induced cognitive decline in normal rats. Biomed Rep 14(1):1","journal-title":"Biomed Rep"},{"issue":"5","key":"3925_CR61","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bbadis.2011.12.002","volume":"1822","author":"S Miriyala","year":"2012","unstructured":"Miriyala S et al (2012) Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta 1822(5):794\u2013814","journal-title":"Biochim Biophys Acta"},{"key":"3925_CR62","unstructured":"Figures Created with Biorender.com"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-021-03925-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T03:01:48Z","timestamp":1725678108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-021-03925-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":62,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["3925"],"URL":"https:\/\/doi.org\/10.1007\/s00018-021-03925-4","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}